STAT+: U.K. advocacy groups threaten court action over a key provision in the pharma trade deal with the U.S.

The UK advocacy groups are threatening court action over a provision in the pharma trade deal with the US, which may allow outsiders to influence decisions on medicine cost-effectiveness. The trade agreement covers pharmaceuticals and imposes zero tariffs on medicines exported from the UK for at least three years. The UK government has pledged to increase spending on medicines and the National Health Service will increase prices paid for medicines.